We are live on !
Find out more
PAP
Persistent Asset Partners Portfolio holdings
AUM
$335M
Turnover
79.96%
1-Year Est. Return
275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
(+25%)
Cap. Flow
-$37.3M
Cap. Flow % of AUM
Cap. Flow %
-11.13%
Top 10 Holdings %
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134
Avg Time Held
Equity + Options
0.1
years
Top 10 Avg Time Held
Equity + Options
0.1
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.1
years
Top 10 Avg Time Held Equity only
0.1
years
Top 20 Avg Time Held Equity only
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Robinhood
HOOD
|
+$16M |
| 2 |
STMicroelectronics
STM
|
+$13.6M |
| 3 |
Amphenol
APH
|
+$10.9M |
| 4 |
Seagate
STX
|
+$7.07M |
| 5 |
Ford
F
|
+$6.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sandisk
SNDK
|
+$18.4M |
| 2 |
Lumentum
LITE
|
+$14.5M |
| 3 |
AXT Inc
AXTI
|
+$13.3M |
| 4 |
Tower Semiconductor
TSEM
|
+$11.9M |
| 5 |
Micron Technology
MU
|
+$10.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.35% |
| 2 | Healthcare | 29.66% |
| 3 | Financials | 6.33% |
| 4 | Miscellaneous | 6.14% |
| 5 | Consumer Discretionary | 5.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
376
CALL
Celldex Therapeutics
CLDX
$2.38B
| $68.8K | 0.02% |
+129
| New | +$4.17K |
2026 Q2
0 quarters
|
|
377
Avalyn Pharma
AVLN
$1.09B
| $67.9K | 0.02% |
+2,064
| New | +$59.6K |
2026 Q2
0 quarters
|
|
378
Entergy
ETR
$50.2B
| $67.8K | 0.02% |
+590
| New | +$66.5K |
2026 Q2
0 quarters
|
|
379
Eli Lilly
LLY
$1.14T
| $67.2K | 0.02% |
56
-1,850
| -97% | -$1.89M |
2025 Q4
2 quarters
|
|
380
CALL
ASML
ASML
$629B
| $67.1K | 0.02% |
+3
| New | +$4.78K |
2026 Q2
0 quarters
|
|
381
Chewy
CHWY
$8.65B
| $66.8K | 0.02% |
+3,399
| New | +$77.2K |
2026 Q2
0 quarters
|
|
382
NRX Pharmaceuticals
NRXP
$113M
| $66.8K | 0.02% |
+16,326
| New | +$53.9K |
2026 Q2
0 quarters
|
|
383
Oceaneering
OII
$4.39B
| $66.2K | 0.02% |
+1,635
| New | +$61.6K |
2026 Q2
0 quarters
|
|
384
Shift4
FOUR
$3.19B
| $66.2K | 0.02% |
+1,362
| New | +$58.9K |
2026 Q2
0 quarters
|
|
385
Entravision Communication
EVC
$584M
| $66.2K | 0.02% |
+5,078
| New | +$36K |
2026 Q2
0 quarters
|
|
386
UroGen Pharma
URGN
$1.71B
| $65.9K | 0.02% |
1,790
-4,034
| -69% | -$109K |
2025 Q1
5 quarters
|
|
387
Guardian Pharmacy Services
GRDN
$2.65B
| $65.8K | 0.02% |
+1,572
| New | +$60.9K |
2026 Q2
0 quarters
|
|
|
388
CALL
Sandisk
SNDK
$197B
| $65.7K | 0.02% |
+3
| New | +$4.28K |
2026 Q2
0 quarters
|
|
389
Brookdale Senior Living
BKD
$2.4B
| $65.6K | 0.02% |
+4,079
| New | +$55.5K |
2026 Q2
0 quarters
|
|
390
Charles Schwab
SCHW
$157B
| $65.6K | 0.02% |
+711
| New | +$64.8K |
2026 Q2
0 quarters
|
|
391
Essent Group
ESNT
$5.92B
| $65.6K | 0.02% |
+1,020
| New | +$61.7K |
2026 Q2
0 quarters
|
|
392
CALL
Intel
INTC
$485B
| $65.3K | 0.02% |
+38
| New | +$3.84K |
2026 Q2
0 quarters
|
|
393
Woodward
WWD
$19.1B
| $65.1K | 0.02% |
+153
| New | +$58K |
2026 Q2
0 quarters
|
|
394
Steris
STE
$22B
| $64.6K | 0.02% |
+307
| New | +$65.8K |
2026 Q2
0 quarters
|
|
395
Equinix
EQIX
$97.4B
| $64.6K | 0.02% |
+62
| New | +$66.4K |
2026 Q2
0 quarters
|
|
396
Life Time Group Holdings
LTH
$9.2B
| $64.4K | 0.02% |
+1,578
| New | +$50.1K |
2026 Q2
0 quarters
|
|
397
Eversource Energy
ES
$24.6B
| $64.2K | 0.02% |
+889
| New | +$61.6K |
2026 Q2
0 quarters
|
|
398
Garmin
GRMN
$56B
| $63.9K | 0.02% |
+269
| New | +$65.4K |
2026 Q2
0 quarters
|
|
399
HEICO Corp Class A
HEI.A
$32.3B
| $63.2K | 0.02% |
+245
| New | +$56K |
2026 Q2
0 quarters
|
|
400
Hilton Grand Vacations
HGV
$2.81B
| $63.2K | 0.02% |
+245
| New | +$11.8K |
2026 Q2
0 quarters
|
|
Similar funds
PI
TFA
SIM
OWM
SS
BIA
TODC
RLIM
Persistent Asset Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.
- Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
- Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
- Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
- Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
- Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
- Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
- Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.
Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.